Role of comprehensive diabetes care in known diabetes patients from western Mumbai region: an observational study

Rohit Sane, Rahul Mandole, Gurudatta Anand Amin, Pravin Ghadigaokar, Sneha Paranjape, Bipin Gond, Prajakta Asnodkar, Aarti Badre, Supriya Shinde, Amirullah Ahmed


Background: The occurrence of Diabetes Mellitus (DM) has been creating a havoc since past few decades on a global platform. As per available literature, prevalence of DM in Mumbai is around 10%. Comprehensive Diabetes Care (CDC) is a form of Ayurvedic therapy which combines panchkarma and diet management. The present study was planned to evaluate the effectiveness of CDC in patients of DM by analysing changes in body mass index (BMI), body weight, OGTT, HbA1c, etc.

Methods: The present study was of retrospective design, conducted at Madhavbaug clinics in western Mumbai. The duration of study was of one year, conducted from October 2018 to September 2019. It included patients diagnosed with type 2 DM i.e. HbA1c>6.5%, who were given CDC therapy.

Results: In the present study, out of 183 type 2 diabetic patients, 99 were males (52%), while 84 were females (48%), thus male: female ratio was 1.17:1. On analysing the results of HbA1c in patients who had completed 12 weeks of CDC therapy, it was found that controlled DM status was seen in 109 patients (59%), while uncontrolled DM status was noted in 33 patients (19%) as compared to 102 patients (58%) at baseline.

Conclusions: From the findings of the present study, it is clear that CDC is effective in the form of increasing number of euglycemic patients at the end of study period, as well as reduction in all glycaemic and anthropometric parameters, and reducing dependency on conventional medicines.


Comprehensive diabetes care, Diabetes mellitus, HbA1c

Full Text:



World Health Organization. Global reports on Diabetes, 2016. Available at: Accessed 21 January 2020.

Sanjeevaiah A, Sushmitha A, Srikanth T. Prevalence of Diabetes Mellitus and its risk factors. IAIM. 2019;6(3):319-24.

Vijayakumar G, Arun R, Kutty V. High Prevalence of Type 2 Diabetes Mellitus and Other Metabolic Disorders in Rural Central Kerala. JAPI. 2009;57:563-7.

Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator. 2009;XXII(1, 2):1-18.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;42(1):S10-5.

Fonseca V, Inzucchi S, Ferrannini E. Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin. Diabetes Care. 2009;32(7):1344-5.

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017.

Garber A. AACE/ ACE comprehensive diabetes management algoritm. Endocrine Practice. 2016;21(4):e1-10.

Manandhar-Shrestha JT, Shrestha H, Prajapati M, Karkee A, Maharjan A. Adverse effects of oral hypoglycemic agents and adherence to them among patients with type 2 diabetes mellitus in Nepal. J Lumbini Medical College. 2017;5(1):34-40.

Egede L, Axon R, Zhao Y. Medications non-adherence in diabetics. Diabetes Care. 2012;35:2533-9.

Arumugam G, Manjula P, Paari N. A review: anti diabetic medicinal plants used for diabetes mellitus. J Acute Dis. 2013:196-200.

Malvi R, Jain S, Khatri S, Patel A, Mishra S. A Review on Antidiabetic Medicinal Plants and Marketed Herbal Formulations. Inter J Pharmaceutical and Biological Archives. 2011;2(5):1344-55.

Gebreyohannes G, Gebreyohannes M. Medicinal values of garlic: A review. Inter J Med Medi Scienc. 2013;5(9):401-8.

Choudhary K, Sharma P, Sharma V. Hypertension and its management through Panchakarma. J Ayurveda Hol Med. 2015;3(3):28-31.

Uebaba K, Xu FH, Ogawa H, Tatsuse T, Wang BH, Hisajima T, et al. Psychoneuroimmunologic effects of ayurvedic oil dripping treatment. J Altern Complement Med. 2008;14:1189-98.

Sane R, Aklujkar A, Patil A, Mandole R. Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label study. Indian Heart J. 2017;69(3):299-304.

Sane R, Ghadigaonkar P, Chaure R, Jain S, Wahane S, Nadapude A, et al. Efficacy of Comprehensive Diabetes Care (CDC) Management Program in Elderly Male Patients of Type II Diabetes Mellitus: A Retrospective Study. Intern J Diabetes Endocrinol. 2018;3(2):29-34.

Rastogi S, Chiappelli F. Hemodynamic effects of Sarvanga Swedana (Ayurvedic passive heat therapy): A pilot observational study. AYU. 2013 Apr-Jun;34(2):154-9.

Perwitasari D, Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. Sage Open. 2016:1-7.

Buse JB, ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. The Ame J Cardiol. 2007 Jun 18;99(12):S21-33.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, et al. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12A): S34-43.

Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. New England J Med. 2008 Jun 12;358(24):2545-59.